U.S. Officials Looking Into Skyrocketing Cost Of Pregnancy Drug

Published: .
Updated: .

America's top health official on Monday said she would look into the controversy over the skyrocketing price of a drug that prevents miscarriages and preterm labor.

The Food and Drug Administration approved a request by KV Pharmaceuticals to manufacture the drug, which has been made by for years by compounding pharmacies for less than $20 a dose, 10TV News reported.

The drug company plans to charge $1,500 per dose.


Ohio Sen. Sherrod Brown on Sunday called for an investigation by the Federal Trade Commission and on Monday the U.S. Health and Human Services Secretary said she will look into the situation.

"I think having a decision made by a pharmaceutical company which dramatically increases the price of a drug that helps women carry pregnancies to term is, is really dangerous and damaging," said Kathleen Sebelius, U.S. health and human services secretary.

Sebelius was in Columbus to talk to officials at Nationwide Children's Hospital.

Watch 10TV News HD and refresh 10TV.com for continuing coverage.

Previous Story:

March 10, 2011: Pregnancy Drug Skyrocketing From $20 To $1,500